Cite

HARVARD Citation

    Gile, J. et al. (2021). FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO precision oncology. pp. 1228-1240. [Online]. 
  
Back to record